Table of contents

  1. Front Matter
    Pages i-xi
  2. Riham Katkhuda, Yun Shin Chun
    Pages 1-10
  3. Arezou Abbasi, Amir A. Rahnemai-Azar, Sean M. Ronnekleiv-Kelly, Daniel E. Abbott, Sharon M. Weber
    Pages 11-20
  4. Janelle F. Rekman, Flavio G. Rocha
    Pages 21-51
  5. Pegah Khoshpouri, Timothy M. Pawlik, Ihab R. Kamel
    Pages 53-66
  6. Georgios Antonios Margonis, George A. Poultsides
    Pages 67-83
  7. Alfredo Guglielmi, Fabio Bagante, Andrea Ruzzenente, Tommaso Campagnaro, Simone Conci, Calogero Iacono
    Pages 85-94
  8. Benjamin J. Swanson
    Pages 95-105
  9. Ning Jin, Laith Abushahin
    Pages 107-121
  10. Guojun Qian, Jinglei Zhang, Feng Shen
    Pages 123-134
  11. Susan Shamimi-Noori, Michael C. Soulen
    Pages 135-150
  12. Florence K. Keane, Theodore S. Hong
    Pages 151-165
  13. Eleonora Milani, Mario Strazzabosco, Luca Fabris, Massimiliano Cadamuro
    Pages 167-182
  14. Jonathan D. Mizrahi, Reham Abdel-Wahab, Milind Javle
    Pages 183-208
  15. Back Matter
    Pages 209-215

About this book


This book provides a comprehensive review of the epidemiology, molecular pathogenesis, diagnosis and treatment of intrahepatic cholangiocarcinoma (ICC).  It brings together an impressive group of international experts in cholangiocarcinoma research and clinical care.  The book was organized and written to aid the clinician’s understanding of emerging research in cholangiocarcinoma and its application to the clinical care of patients with ICC. Each chapter details the scientific evidence to support clinical decisions that are needed to care for these complex patients.  Focused chapters detail the epidemiology, diagnostic evaluation, as well as staging and prognosis of this disease. In addition to dedicated chapters on surgical management of ICC, a broad emphasis on locoregional therapies, including percutaneous ablation and transarterial therapies, is included. An up-to-date overview of the molecular pathogenesis and pathological assessment of ICC is detailed prior to chapters focusing on systemic chemotherapy and emerging novel therapy options.

Intrahepatic Cholangiocarcinoma is not only an invaluable resource for many as they seek to provide the best multidisciplinary cancer care to patients with ICC, but also an opportunity to identify new avenues of scientific discovery that lead to significant advances in the diagnosis and management of ICC.


Molecular Pathogenesis Nodal Basin Systemic Therapy ICC Intra-arterial Therapy

Editors and affiliations

  • Timothy M. Pawlik
    • 1
  • Jordan M. Cloyd
    • 2
  • Mary Dillhoff
    • 3
  1. 1.Wexner Medical CenterThe Ohio State UniversityColumbusUSA
  2. 2.Wexner Medical CenterThe Ohio State UniversityColumbusUSA
  3. 3.Wexner Medical CenterThe Ohio State UniversityColumbusUSA

Bibliographic information